Amelanotic Melanoma: A Great Masquerader.

Area of Science:

• Oncology
• Dermatopathology
• Immunohistochemistry

Background:

• Malignant melanoma exhibits significant morphological and immunohistochemical variability, complicating diagnosis.
• Amelanotic melanoma presents unique challenges due to its lack of pigment, diverse clinical appearances, and varied histology, often leading to misdiagnosis.
• Immunohistochemistry is crucial for diagnosing malignant tumors, including melanoma, but aberrant antigen expression can pose diagnostic difficulties.

Observation:

• A 72-year-old male initially presented with a condition misdiagnosed as sarcomatoid anaplastic plasmacytoma.
• The patient's initial presentation included atypical clinical features and variant morphology.
• Subsequent biopsy from a different site revealed aberrant antigenic expression.

Findings:

• The case presented multiple diagnostic challenges, including atypical clinical presentation, variant morphology, and aberrant antigenic expression.
• Initial misdiagnosis underscores the difficulty in identifying amelanotic melanoma.
• A definitive diagnosis of amelanotic melanoma was established after a 5-month diagnostic delay.

Implications:

• Accurate and timely diagnosis of amelanotic melanoma is critical for appropriate patient management.
• This case emphasizes the indispensable role of immunohistochemistry in diagnosing challenging oncological cases.
• Awareness of amelanotic melanoma's masquerading potential is essential for clinicians and pathologists to avoid diagnostic errors.